Cite
HARVARD Citation
Annulli, G. et al. (n.d.). T04.02.18 SWITCHING FROM INFLIXIMAB ORIGINATOR TO THE BIOSIMILAR (CT-P13) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A RETROSPECTIVE STUDY ABOUT EFFECTIVENESS AND SAFETY. Digestive and liver disease. pp. S134-S135. [Online].